Home | Healthcare | GLP-1 Receptor Agonist Market Report by Product (Victoza, Ozempic, Trulicity, Bydureon, Saxenda, and Others), Route of Administration (Parenteral, Oral), Application (Type 2 Diabetes Mellitus, Obesity, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics, Online Pharmacies), and Region 2026-2034 Report Format: PDF+Excel | Report ID: SR112026A13049 Report Description Table of Contents Methodology Request Sample GLP-1 Receptor Agonist Market Size: The global GLP-1 receptor agonist market size reached USD 29.0 Billion in 2025
It depends on your health goals
Breastfeeding considerations also differ between the drug classes, with insulin generally considered compatible with breastfeeding while GLP-1 drugs are not recommended
doi: 10.1073/pnas.0901043106 67 YuCXLiSWhortonAR
For more injection guidance specific to semaglutide injection techniques , the detailed guide covers nuances for different body compositions
Diabetes Obes Metab (2018) 20:22109